Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
At Bristol(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
92
Papers
366
Citations
10
h-index
10
i10-index
Vicki Black is an academic researcher from At Bristol. The author has contributed to research in topics: Veterinary Oncology Research & Veterinary Medicine and Surgery & Veterinary Orthopedics and Neurology. The author has an h-index of 10, co-authored 79 publications.
ORCID: 0000-0002-8486-8127https://doi.org/10.1016/s2213-8587(23)00253-x
https://doi.org/10.1111/jsap.13190
https://doi.org/10.1016/s1473-3099(25)00093-3
https://doi.org/10.1016/j.eclinm.2025.103080
Click to start Chat